City of Hope

This is your central portal for breaking news, the latest research and important updates from City of Hope. Bookmark this page and check back often for updates.

Meeting NewsPerspective

Novel risk stratification model outperforms standard prediction tools for myelodysplastic syndrome

December 3, 2018
SAN DIEGO — A personalized risk prediction model developed using machine learning showed utility as a predictive and prognostic tool among…
Meeting NewsPerspective

Ibrutinib plus CD19-specific CAR T-cell therapy may benefit patients with relapsed or refractory CLL

December 2, 2018
SAN DIEGO — Administration of ibrutinib beginning 2 weeks prior to leukapheresis and continuing until 3 months after CD19-specific chimeric…

Arti Hurria, MD, remembered as ‘true giant’ in oncology, tireless advocate for patients

November 15, 2018
Arti Hurria, MD, felt she found her perfect fit in the field of medicine. The colleagues who continue to express an overwhelming sense of personal…

Oncologists, hematologists elected to National Academy of Medicine

October 18, 2018
The National Academy of Medicine announced the election of 75 regular members and 10 international members. Election to the academy —…
Feature

Novel wireless device shows potential for detecting cardiovascular disease among childhood cancer survivors

September 7, 2018
A wireless device designed to detect cardiovascular disease among childhood cancer survivors treated with anthracycline chemotherapy appeared…

City of Hope appoints chief operating officer

July 26, 2018
Jeff A. Walker has been appointed chief operating officer at City of Hope. Walker — whose appointment will take effect Aug. 1 — will…
Meeting News

HemOnc Today honors Next Gen Innovators at ASCO

HemOnc Today, June 25, 2018
HemOnc Today unveiled its second class of Next Gen Innovators during ASCO Annual Meeting. The publication’s 71 Next Gen Innovators —…
Meeting NewsPerspective

Nivolumab plus chemotherapy prolongs PFS in lung cancer with PD-L1 less than 1%

June 12, 2018
CHICAGO — Therapy with nivolumab plus chemotherapy improved PFS compared with chemotherapy alone among patients with newly diagnosed advanced…

Cancer centers join forces to eliminate HPV-related cancers

June 7, 2018
The nation’s 70 NCI-designated cancer centers issued a joint statement today calling for increased gender-neutral HPV vaccination and…
Meeting NewsPerspective

Nivolumab shows durable benefit for advanced melanoma

June 4, 2018
CHICAGO — Patients with surgically resected stage III or stage IV melanoma at high risk for recurrence maintained longer RFS after adjuvant…
Feature

City of Hope researchers assess novel stem cell transplant procedure

May 18, 2018
The California Institute for Regenerative Medicine awarded a $5.7 million grant to City of Hope to fund a trial of a novel hematopoietic stem cell…

American Association for Cancer Research presents scientific awards

April 15, 2018
The American Association for Cancer Research will present several scientific awards during its annual meeting, scheduled for April 14-18 in Chicago…

American Association for Cancer Research names academy fellows

April 14, 2018
The American Association for Cancer Research announced the newly elected fellows of the AACR Academy. The 2018 class will be inducted during the AACR…
Cover Story

Larger trials needed to confirm benefit of targeted therapies, immunotherapy for brain metastases

HemOnc Today, February 10, 2018
Brain metastases are a common complication of a variety of cancer types and a major cause of morbidity and mortality. As patients with cancer are…
Meeting News

Brentuximab vedotin, ibrutinib combination appears effective for Hodgkin lymphoma

February 6, 2018
ATLANTA — A combination of brentuximab vedotin with ibrutinib appeared tolerable and safe among patients with relapsed or refractory Hodgkin…
Meeting News

Brentuximab vedotin, nivolumab combination appears active for Hodgkin lymphoma

January 15, 2018
ATLANTA — A combination of brentuximab vedotin with nivolumab appeared tolerable and safe among patients with relapsed or refractory Hodgkin…

HemOnc Today honors inaugural Next Gen Innovators

HemOnc Today, January 10, 2018
HemOnc Today honored its inaugural class of Next Gen Innovators during the ASH Annual Meeting and Exposition. The Next Gen Innovators are a highly…

Survivors of adolescent and young adult lymphoma, leukemia face elevated risk for subsequent cancers

December 14, 2017
ATLANTA — Survivors of adolescent and young adult hematologic cancers demonstrated increased risk for subsequent malignant neoplasms compared…
Meeting NewsPerspective

Patient characteristics correlate with toxicity, response to CAR T-cell therapy in diffuse large B-cell lymphoma

December 12, 2017
ATLANTA — The presence of inflammation and high tumor burden prior to chimeric antigen receptor T-cell treatment indicated increased risk for…

AACR president to lead City of Hope National Medical Center

HemOnc Today, January 25, 2018
Michael A. Caligiuri, MD, has been named president and physician-in-chief at City of Hope National Medical Center. Caligiuri — president of…